K C Gatter

Author PubWeight™ 368.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994 21.00
2 An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994 5.34
3 The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000 5.21
4 Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990 4.42
5 Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002 4.22
6 bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993 4.05
7 Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998 3.67
8 Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med 1983 3.63
9 Ki67 protein: the immaculate deception? Histopathology 2002 3.61
10 The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem 2000 3.52
11 Transferrin receptor on endothelium of brain capillaries. Nature 1984 3.37
12 Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983 3.23
13 Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001 3.10
14 JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990 3.10
15 Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990 3.07
16 Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A 1991 2.82
17 KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989 2.82
18 Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001 2.71
19 Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 1982 2.69
20 Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995 2.52
21 Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest 1986 2.42
22 Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990 2.40
23 Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet 1985 2.40
24 Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001 2.38
25 Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet 1984 2.25
26 Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994 2.21
27 Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 2003 2.20
28 Association between platelet microthrombi and finger clubbing. Lancet 1991 2.20
29 Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997 2.19
30 Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 1998 2.05
31 Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992 2.03
32 Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet 1990 1.86
33 Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol 1989 1.85
34 bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 1994 1.81
35 Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology 1987 1.78
36 The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984 1.77
37 Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985 1.76
38 Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991 1.72
39 A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol 1995 1.67
40 The role of immunocytochemistry in diagnostic pathology. J Clin Pathol 1987 1.59
41 Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993 1.58
42 The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer 2009 1.57
43 An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology 1984 1.55
44 Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 1995 1.54
45 New approach to assessing lung tumours in man. J Clin Pathol 1986 1.50
46 The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas. J Pathol 1989 1.50
47 Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993 1.49
48 Ways of escape: are all tumours angiogenic? Histopathology 2001 1.48
49 Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 1992 1.48
50 The bone marrow trephine biopsy: a review of normal histology. Histopathology 1993 1.48
51 Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol 2003 1.47
52 Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet 1985 1.46
53 Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res 2001 1.46
54 Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995 1.45
55 Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 1996 1.42
56 Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol 1987 1.41
57 MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol 1998 1.41
58 Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol 1988 1.41
59 Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 2001 1.41
60 Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol 1986 1.40
61 Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 1998 1.37
62 Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001 1.36
63 The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996 1.33
64 Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat Oncol Biol Phys 2001 1.32
65 An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol 1985 1.31
66 Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 2010 1.30
67 Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Eur J Clin Invest 2007 1.26
68 Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. J Clin Pathol 1989 1.26
69 The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 2004 1.26
70 Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 2000 1.25
71 Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997 1.25
72 Langerhans' cells in human cervical epithelium: an immunohistological study. Br J Obstet Gynaecol 1983 1.25
73 Granular cell tumours revisited. An immunohistological and ultrastructural study. Histopathology 1988 1.24
74 Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues. Am J Pathol 1987 1.23
75 Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer 2009 1.22
76 Human lung tumours: a correlation of antigenic profile with histological type. Histopathology 1985 1.22
77 Ki-67 immunostaining and survival in operable lung cancer. Histopathology 1991 1.22
78 LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005 1.22
79 Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 1988 1.21
80 Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clin Cancer Res 1998 1.21
81 Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. J Clin Pathol 1988 1.20
82 Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989 1.20
83 Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 1997 1.19
84 Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer 1997 1.19
85 Osteoclasts contain macrophage and megakaryocyte antigens. J Pathol 1986 1.19
86 Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clin Cancer Res 2000 1.19
87 Giant cell myocarditis: evidence for the macrophage origin of the giant cells. J Clin Pathol 1985 1.19
88 Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol 1989 1.19
89 An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. Br J Cancer 1984 1.19
90 Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology 2005 1.18
91 Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 1986 1.17
92 Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol 1985 1.17
93 Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol 1998 1.17
94 Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 1992 1.16
95 Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 1990 1.16
96 Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer 2002 1.16
97 A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues. Immunology 1983 1.16
98 Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 1998 1.15
99 Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993 1.13
100 Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 1996 1.13
101 Tumour angiogenesis. J Pathol 1996 1.13
102 Lymphoma classification proposal: clarification. Blood 1995 1.13
103 An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J Clin Pathol 1985 1.12
104 Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res 1997 1.12
105 Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 1997 1.11
106 Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. Int J Cancer 1992 1.11
107 The organization of the connections between the cortex and the claustrum in the monkey. Brain Res 1982 1.11
108 Expression of mutant p53 in melanoma. Cancer Res 1991 1.10
109 Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens. J Clin Pathol 1988 1.10
110 Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Am J Clin Pathol 1992 1.10
111 The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 2003 1.09
112 The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol 1984 1.09
113 Freeze-dried paraffin-embedded human tissue for antigen labelling with monoclonal antibodies. Lancet 1984 1.09
114 Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993 1.08
115 Is it necessary to embed bone marrow biopsies in plastic for haematological diagnosis? Histopathology 1987 1.08
116 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 2000 1.08
117 p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration. J Pathol 1993 1.07
118 The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 1992 1.07
119 Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. Br J Cancer 1988 1.07
120 Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies. Br J Haematol 1984 1.06
121 The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. Br J Haematol 1990 1.06
122 New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol 1986 1.06
123 Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer 1998 1.04
124 Cellular heterogeneity in lung cancer. Histopathology 1986 1.04
125 Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol 1986 1.04
126 The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol 1995 1.04
127 p53 expression in colorectal adenomas. Am J Pathol 1993 1.04
128 Langerhans' cells and T cells in human skin tumours: an immunohistological study. Histopathology 1984 1.04
129 Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer 2003 1.03
130 Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst 1997 1.03
131 Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 1994 1.02
132 Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 1999 1.02
133 CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990 1.02
134 The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer 2001 1.02
135 Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol 1983 1.02
136 Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis. Br J Cancer 1998 1.02
137 Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci 1991 1.01
138 Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 1996 1.01
139 Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 2000 1.00
140 Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 1997 1.00
141 Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology 1995 1.00
142 Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. Oncol Res 2000 0.99
143 Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. J Clin Pathol 1990 0.99
144 Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res 1995 0.99
145 The intrinsic connections of the cortex of area 4 of the monkey. Brain 1978 0.99
146 The projection of the basal nucleus of Meynert upon the neocortex in the monkey. Brain Res 1983 0.98
147 An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Pathol 1986 0.98
148 Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res 1991 0.97
149 Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995 0.97
150 An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat. Brain 1980 0.97
151 Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates. Am J Dermatopathol 1986 0.97
152 An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987 0.96
153 NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material. J Pathol 1991 0.96
154 Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer 1992 0.95
155 A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. Immunology 1986 0.95
156 Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence. Cancer Res 1997 0.94
157 Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 2000 0.94
158 Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. Br J Haematol 1995 0.94
159 The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat 1995 0.94
160 Primary Hodgkin's disease of the lung. Pathology 1995 0.93
161 BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis. J Clin Pathol 2007 0.93
162 Monoclonal antibody JC1: new reagent for studying cell proliferation. J Clin Pathol 1992 0.93
163 Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 1998 0.93
164 The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis. J Pathol 2001 0.93
165 The L1 antigen and squamous metaplasia in the bladder. Histopathology 1991 0.93
166 CD44 and cancer screening. Lancet 1993 0.92
167 Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Cancer Res 1999 0.92
168 Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J Pathol 1997 0.92
169 Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia. J Pathol 1996 0.92
170 Expression of the Ig-associated heterodimer (mb-1 and B29) in Hodgkin's disease. Histopathology 1993 0.91
171 Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J Clin Pathol 1986 0.91
172 Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood 1987 0.91
173 A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. Br J Cancer 2005 0.91
174 Cellular distribution of human leucocyte adhesion molecule ICAM-3. J Clin Pathol 1994 0.91
175 Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. Br J Cancer 2011 0.91
176 Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. J Pathol 2001 0.91
177 Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol 2000 0.90
178 A study of adhesion molecules as markers of progression in malignant melanoma. J Pathol 1992 0.90
179 Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 1987 0.90
180 bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer. Clin Exp Metastasis 1999 0.90
181 Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 2007 0.90
182 The diagnosis of low-grade peripheral B-cell neoplasms in bone marrow trephines. Br J Haematol 2000 0.90
183 Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). J Pathol 1999 0.90
184 Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 1994 0.90
185 C-erbB-2 oncoprotein expression in operable non-small cell lung cancer. Anticancer Res 1996 0.89
186 CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. Br J Cancer 2006 0.89
187 A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology 1994 0.89
188 The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. Histopathology 2005 0.88
189 The use of monoclonal antibodies for histopathologic diagnosis of human malignancy. Semin Oncol 1982 0.88
190 Cell lineage in Hodgkin's disease. Lancet 1987 0.88
191 Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis 1999 0.88
192 Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer Res 2002 0.88
193 Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates. Arch Dermatol Res 1987 0.87
194 Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. Br J Cancer 2012 0.87
195 An immunohistological study of benign and malignant skin tumours: epithelial aspects. Histopathology 1984 0.87
196 Retrograde cell degeneration in the basal nucleus in monkey and man. Brain Res 1983 0.87
197 The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Br J Cancer 2001 0.87
198 Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39. Br J Cancer 2000 0.87
199 Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann Oncol 1997 0.86
200 Cervical wart virus infection, intraepithelial neoplasia and carcinoma; an immunohistological study using a panel of monoclonal antibodies. Br J Obstet Gynaecol 1983 0.86
201 The characterization of two monoclonal anti-keratin antibodies and their use in the study of epithelial disorders. Histopathology 1985 0.86
202 Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour. Br J Cancer 2000 0.86
203 Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodies. Am J Hematol 1987 0.86
204 Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 1995 0.86
205 Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 1995 0.85
206 Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections. J Clin Pathol 1990 0.85
207 Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol 1993 0.85
208 Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas. J Surg Oncol 2006 0.85
209 An immunoelectron microscopic study of human placenta using three monoclonal antibodies. Placenta 1983 0.85
210 BNIP3 expression in follicular lymphoma. Histopathology 2007 0.84
211 The projection of the locus coeruleus upon the neocortex in the macaque monkey. Neuroscience 1977 0.84
212 The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994 0.84
213 Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas. Virchows Arch A Pathol Anat Histopathol 1987 0.84
214 Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides. J Clin Pathol 1986 0.83
215 Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. Br J Cancer 1992 0.83
216 The distribution of the deleted in colon cancer (DCC) protein in human tissues. Cancer Res 1995 0.83
217 Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. Br J Cancer 2007 0.83
218 The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. Am J Clin Pathol 1985 0.83
219 Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines. Histopathology 1990 0.83
220 The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma. Histopathology 1996 0.82
221 Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer 2002 0.82
222 T-cell origin of Lennert's lymphoma. Br J Haematol 1986 0.82
223 Langerhans cells in human lung tumours: an immunohistological study. Histopathology 1989 0.82
224 Role of immunohistochemistry in diagnosis of nasopharyngeal tumours. J Clin Pathol 1985 0.82
225 TAL-1 protein expression in vascular lesions. J Pathol 1997 0.82
226 An electron microscopic study of the termination of intracortical axons upon Betz cells in area 4 of the monkey. Brain 1978 0.82
227 Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract. J Clin Pathol 1988 0.82
228 An investigation into the nature of giant cells in cardiac and skeletal muscle. Hum Pathol 1988 0.82
229 Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer. Int J Cancer 1999 0.81
230 Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol 2000 0.81
231 Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124). Br J Cancer 1996 0.81
232 Immunocytochemistry in the detection of bone marrow metastases in patients with primary lung cancer. Br J Cancer 1986 0.81
233 Thymidine phosphorylase expression in Kaposi sarcoma. J Clin Pathol 1996 0.81
234 Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 2003 0.81
235 Biochemical evidence that cytokeratins are present in smooth muscle. Br J Exp Pathol 1988 0.81
236 Heterogeneity of CD3 antigen expression in T-cell lymphoma. Histopathology 1993 0.81
237 Practical value of genotypic analysis for diagnosing lymphoproliferative disorders. J Clin Pathol 1987 0.81
238 Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis 2013 0.81
239 Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? Oncol Res 1999 0.81
240 Human lung tumours: does intermediate filament co-expression correlate with other morphological or immunocytochemical features? Histopathology 1987 0.81
241 Detection of 14;18 chromosomal translocation in paraffin-embedded lymphoma tissue. Lancet 1989 0.81
242 Expression of intermediate filament proteins in normal and diseased thyroid glands. J Clin Pathol 1987 0.80
243 Expression of the p53 protein in a spectrum of astrocytic tumours. J Pathol 1992 0.80
244 Immunocytochemical analysis of cytocentrifuged fine needle aspirates. A study based on lung tumors aspirated in vitro. Anal Quant Cytol Histol 1989 0.80
245 The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias. Am J Clin Pathol 1988 0.80
246 Platelet-derived endothelial cell growth factor/thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies. Hum Pathol 1997 0.80
247 Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. J Clin Pathol 1995 0.80
248 Dendritic reticulum cells in reactive lymph nodes and tonsils: an immunohistological study. Histopathology 1986 0.80
249 Giant cell myocarditis associated with lymphoma: an immunocytochemical study. J Clin Pathol 1987 0.80
250 Epithelial membrane antigen expression by the perineurium of peripheral nerve and in peripheral nerve tumours. Histopathology 1988 0.79
251 Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin Exp Metastasis 1998 0.79
252 Epithelial membrane antigen in hematopoietic neoplasms. Hum Pathol 1986 0.79
253 Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 1995 0.79
254 Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39. Anticancer Res 2002 0.79
255 Thymidine phosphorylase expression in normal and hyperplastic endometrium. J Clin Pathol 2000 0.79
256 More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 2000 0.79
257 EBV latent membrane protein (LMP-1) and bcl-2 protein expression in Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders. Histopathology 1996 0.79
258 Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma. J Clin Pathol 1992 0.78
259 c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer. J Immunother 2000 0.78
260 Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer. Anticancer Res 1998 0.78
261 Epithelial membrane antigen expression by meningiomas, and the perineurium of peripheral nerve. Arch Pathol Lab Med 1987 0.78
262 p53 Overexpression in laryngeal squamous cell carcinoma and dysplasia. Clin Mol Pathol 1995 0.78
263 The expression of the CD3 antigen in Hodgkin's disease. Histopathology 1989 0.78
264 Measuring proliferation in routine fine needle aspirates. Immunocytochemical detection of bromodeoxyuridine incorporation and Ki-67 expression in breast aspirates. Cytopathology 1992 0.78
265 Immunohistochemical study of mammary and extra-mammary Paget's disease. Histopathology 1984 0.78
266 Schistosomiasis-associated squamous lesions of the bladder. Expression of low molecular weight cytokeratin proteins. Br J Urol 1987 0.78
267 CD68 reactivity of non-macrophage derived tumours in cytological specimens. J Clin Pathol 1993 0.78
268 Monoclonal antibodies in diagnostic pathology: techniques and applications. J Biol Response Mod 1983 0.77
269 Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Hum Pathol 1992 0.77
270 Immunohistological reactivity pattern of the anti-cutaneous T-cell lymphoma antibody BE2. Br J Dermatol 1986 0.77
271 CD30 expression in follicular lymphoma. Histopathology 1991 0.77
272 EBM/11 reactivity in malignant histiocytosis. J Clin Pathol 1988 0.77
273 Which antibodies for diagnostic pathology? Histopathology 1987 0.76
274 Reversible p53 expression in lung cancer. Lancet 1992 0.76
275 An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am J Clin Pathol 1993 0.76
276 bcl-2 immunoexpression in MALT-lymphomas. Hum Pathol 1996 0.75
277 Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells. J Clin Pathol 1986 0.75
278 NPM-ALK gene fusion and Hodgkin's disease. Blood 1997 0.75
279 Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance. Br J Cancer 1996 0.75
280 Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol 1995 0.75
281 The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumours. Br J Cancer 1985 0.75
282 Monoclonal antibody Leu-22. Am J Clin Pathol 1990 0.75
283 Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression. Br J Cancer 1996 0.75
284 Role of angiogenesis in benign, premalignant and malignant vulvar lesions. J Reprod Med 2000 0.75
285 Pulsed field gel electrophoresis on frozen tumour tissue sections. J Clin Pathol 1992 0.75
286 Alveolar soft part sarcoma: ultrastructural and immunohistological studies with monoclonal antibodies. Br J Clin Pract 1984 0.75
287 Monoclonal antibodies that recognize the type-2 activin receptor, ACTR2. Hybridoma 1994 0.75
288 Immunophenotyping of Nigerian cases of non-Hodgkin's lymphomas on paraffin sections. Histopathology 1991 0.75
289 Neoplastic angioendotheliosis--further evidence supporting a lymphoid origin. Histopathology 1986 0.75
290 Use of bronchial brushings in the immunocytochemical assessment of human lung tumors. Acta Cytol 1988 0.75
291 An electron microscopic study of retrograde and orthograde transport of horseradish peroxidase to the lateral geniculate nucleus of the monkey. Brain Res 1975 0.75
292 An immunofluorescent study of the ampicillin rash. Clin Allergy 1982 0.75
293 Distribution of the cdc2 gene product in normal tissues: an immunocytochemical study using four new monoclonal antibodies. Histopathology 1994 0.75
294 [Large cell anaplastic lymphomas in the immunocompromised host]. Verh Dtsch Ges Pathol 1991 0.75
295 The prognostic significance of immunophenotype in high-grade non-Hodgkin's lymphoma. Histopathology 1989 0.75
296 Detection of p53 in Hodgkin's disease using the monoclonal antibody PAb248. J Pathol 1996 0.75
297 Not another lymphoma classification! Br J Haematol 1995 0.75
298 Immunosuppression and thrombosis in renal transplantation: an immunohistological study. Histopathology 1990 0.75
299 Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas. Angiogenesis 1998 0.75
300 The cortical relationships of certain basal ganglia and the cholinergic basal forebrain nuclei. Brain Res 1983 0.75
301 Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence. Oncol Res 2000 0.75
302 Does nodular lymphocyte predominant Hodgkin's disease arise from progressively transformed germinal centres? A case report with an unusually prolonged history. Histopathology 1987 0.75
303 The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-up. Clin Radiol 1988 0.75
304 Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas. Clin Exp Metastasis 2000 0.75
305 Certain connections of the visual cortex of the monkey shown by the use of horseradish peroxidase. Brain Res 1975 0.75
306 T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic, and immunohistochemical analysis of five cases. Cancer 1985 0.75
307 Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology 2002 0.75
308 Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. Hum Pathol 1988 0.75
309 Bcl-2 and p53 expression in stage I endometrial carcinoma. Anticancer Res 1999 0.75
310 From hyperplasia to neoplasia and invasion: angiogenesis in the colorectal adenoma-carcinoma model. Adv Exp Med Biol 2000 0.75
311 The second K Prathap memorial lecture. Cancer of the lung: an immunocytochemical, histological and ultrastructural study. Malays J Pathol 1987 0.75